Do Bones Make Blood? Explaining the Process

Bones are, in fact, the body’s primary blood-cell factory. The soft, spongy tissue inside them, called bone marrow, is where virtually all of your red blood cells, platelets, and most white blood cells are produced throughout your entire life.¹ This process, known as hematopoiesis, is far more dynamic and tightly regulated than most people realize, involving stem cells, hormonal signals from the kidneys, a built-in quality-control system at the blood vessel wall, and even a daily rhythm timed to your sleep cycle.

Where Inside Bone Does Blood Get Made

Not every part of a bone participates in blood production. The hard outer shell you think of as “bone” is compact tissue that provides structural strength. Blood production happens deeper inside, in cavities filled with marrow. Two types of marrow exist: red marrow, which is the active blood-producing tissue, and yellow marrow, which is mostly fat and largely inactive.

In newborns and young children, red marrow fills nearly every bone in the body. As you grow, an orderly conversion takes place. In the long bones of the legs, for instance, red marrow in the central shaft converts to yellow marrow during the first decade of life, followed by conversion in the ends of those bones over the next ten years, with an adult pattern settling in by roughly age 24.² By adulthood, active red marrow is concentrated in the flat bones: the pelvis, sternum, ribs, skull, and vertebrae, along with the ends of the femur and humerus. The rest has been gradually replaced by fat-storing cells.³

This matters because it means the body’s blood-making capacity shrinks with age. When serious demand arises, such as after major blood loss or in certain diseases, the body can reverse this process and convert yellow marrow back to red marrow, a phenomenon called reconversion.⁴ It is essentially the body reactivating retired factories to meet surging demand.

The Stem Cells That Start Everything

All blood cells trace back to a single type of parent cell: the hematopoietic stem cell, or HSC. These cells are rare, making up a tiny fraction of marrow cells, but they are remarkably versatile. An HSC can copy itself to maintain the stem cell pool, or it can begin differentiating down one of several pathways to produce the various blood cell types the body needs.

HSCs do not float around randomly inside the marrow. They occupy a specialized microenvironment called a niche, located near blood vessels. This niche is created partly by certain support cells and the cells lining the blood vessels themselves.⁵ The niche acts like a control room, providing chemical signals that tell stem cells when to stay dormant, when to divide, and which type of blood cell to become. Without this tightly controlled environment, stem cells could exhaust themselves by dividing too quickly or produce the wrong mix of cells.

When an HSC begins to differentiate, it moves through a branching tree of increasingly specialized precursor cells. Early on, it commits to one of a few major lineages: one path leads toward red blood cells and platelets, another toward the various types of white blood cells involved in immune defense, and others toward cells that fight infections in different ways.¹ Each step along these paths is a one-way door. Once a precursor cell has committed to becoming, say, a red blood cell, it cannot change course and become a platelet instead.

How Red Blood Cells Are Built

Red blood cells are the workhorses of the blood, carrying oxygen from your lungs to every tissue in your body and ferrying carbon dioxide back. Your marrow produces roughly two million of them every second, a staggering output that reflects both how essential they are and how short their lifespan is (about 120 days).

The production process, called erythropoiesis, involves a precursor cell going through several rounds of division and maturation. At each stage, the developing cell gets smaller and accumulates hemoglobin, the iron-containing protein that binds oxygen. The final and most dramatic step is enucleation: the developing cell physically ejects its own nucleus. The result is a reticulocyte, an almost-mature red blood cell, and a small package containing the discarded nucleus, which gets cleaned up by nearby cells.⁶

Why throw away the nucleus? It comes down to flexibility. Red blood cells need to squeeze through capillaries that are narrower than they are. A bulky nucleus would make that impossible. By ditching it, the cell becomes a flexible disc that can fold and compress to navigate the tightest blood vessels in your body.⁷ This also frees up more internal space for hemoglobin, boosting the cell’s oxygen-carrying capacity.⁸ It is one of the more unusual tricks in biology: a cell deliberately destroying a part of itself to do its job better.

Platelets Form by a Completely Different Method

Platelets, the tiny cell fragments responsible for blood clotting, are not made by cell division in the traditional sense. Their parent cells, called megakaryocytes, are among the largest cells in the marrow. Instead of splitting in two, a megakaryocyte extends long, branching tentacle-like projections called proplatelets directly into the walls of nearby blood vessels.⁹ These projections then fragment, shedding platelets into the flowing blood like beads breaking off a string.

This mechanism means that a single megakaryocyte can produce thousands of platelets before it is spent. The process is driven by the cell’s internal skeleton, which pushes the proplatelet extensions outward and into the marrow’s blood-filled channels, called sinusoids.¹⁰ It is a strikingly efficient system. Rather than building each platelet from scratch as a separate cell, the body builds one giant factory cell that mass-produces thousands of identical fragments.

White Blood Cells and the Thymus Detour

White blood cells, or leukocytes, are the immune system’s soldiers. Several different types exist, and while most are produced and fully mature in the bone marrow, one important type takes a detour. T cells, which coordinate and execute many immune responses, begin their life in the marrow but must travel to a small organ behind the breastbone called the thymus to complete their education.

Precursor cells produced by HSCs in the bone marrow are periodically released into the bloodstream and travel to the thymus, where they undergo an intensive selection process. Cells that can recognize foreign invaders without attacking the body’s own tissues survive; those that fail are destroyed. This process requires a steady supply of new precursors from the marrow, making the bone marrow-to-thymus pipeline essential for a functioning adaptive immune system.¹¹

Other white blood cells, such as neutrophils and monocytes, mature entirely within the marrow and are released directly into the blood when ready. The marrow keeps a large reserve of these cells, ready to flood the circulation during an infection.

The Gatekeepers at the Blood Vessel Wall

Once blood cells are made, they still need to get from the marrow into the bloodstream. This exit is not a free-for-all. The marrow’s internal blood vessels, the sinusoids, are lined with a thin layer of cells that act as a selective barrier. Mature, healthy cells can pass through; immature or defective cells are held back.

The way cells cross this barrier is unusual. Rather than slipping between the lining cells, exiting blood cells actually push through individual lining cells. The cell being released presses against the vessel wall, causing it to thin and form a tight-fitting pore. The blood cell squeezes through this temporary opening and enters the bloodstream, after which the pore closes behind it.¹²

Additional stromal cells, sometimes called barrier cells, wrap around these blood vessels and extend thin processes into the vessel wall. They reinforce the barrier and help prevent the premature release of immature cells.¹³ This quality-control step is crucial. If immature cells were released into circulation, they would be functionally useless, and their presence in the blood is actually a clinical warning sign that something is wrong with the marrow.

How the Kidneys Tell the Marrow What to Do

The bone marrow does not decide on its own how many red blood cells to make. That signal comes from the kidneys. When the kidneys detect that oxygen levels in the blood are low, whether from blood loss, high altitude, or lung disease, specialized cells in the kidney ramp up production of a hormone called erythropoietin (EPO). EPO travels through the blood to the bone marrow, where it binds to receptors on red blood cell precursors and tells them to survive, multiply, and mature faster.¹⁴

The oxygen-sensing mechanism behind this is elegant. When oxygen drops, a molecular sensor in kidney cells stabilizes and activates genes that boost EPO production.¹⁵ When oxygen levels are adequate, the sensor is broken down before it can act, keeping EPO production low. This creates a feedback loop: low oxygen triggers more red blood cell production, which raises oxygen-carrying capacity, which brings oxygen levels back up and quiets the signal.

This is why kidney disease so often causes anemia. Damaged kidneys produce less EPO, and without that hormonal signal, the marrow does not receive the instruction to make enough red blood cells. Synthetic EPO, given by injection, is one of the most common treatments for anemia in people with chronic kidney disease. It is also the substance that fueled some of the most notorious doping scandals in endurance sports, because artificially boosting red blood cell production gives athletes an edge in oxygen delivery to muscles.

Nutrients the Marrow Cannot Work Without

Even with the right hormonal signals, blood production stalls without certain raw materials. The most important are iron, vitamin B12, and folate. Iron is needed in enormous quantities because it is the central atom in hemoglobin. Without enough iron, the marrow produces red blood cells that are smaller and carry less oxygen, leading to iron-deficiency anemia, the most common nutritional deficiency worldwide.¹⁶

Vitamin B12 and folate serve a different function. Both are essential for DNA synthesis, which means they are critical during the rapid cell division that blood production demands. When either is lacking, the marrow produces abnormally large, dysfunctional red blood cells, a condition called megaloblastic anemia. The cells are big because they fail to divide properly, so they accumulate excess material without completing their normal maturation steps. This is why doctors checking for anemia look not just at how many red blood cells you have, but at their size and shape, which can point toward the underlying nutritional cause.

When Blood Production Fails

Several diseases can cripple the marrow’s ability to make blood. In aplastic anemia, the immune system mistakenly attacks the stem cells in the marrow, destroying the very cells that give rise to all blood cell types. The result is a dangerous shortage of red blood cells, white blood cells, and platelets simultaneously. Research has shown this destruction is driven by immune cells that mount an autoimmune assault against the stem and precursor cells, a process that intensifies as the disease progresses.¹⁷

Leukemias represent a different kind of failure. In these cancers, a blood cell precursor acquires mutations that cause it to multiply uncontrollably. The cancerous cells crowd out normal marrow, suppressing the production of healthy blood cells. Treatment often involves chemotherapy to kill the abnormal cells, sometimes followed by a bone marrow transplant to replace the destroyed marrow with healthy donor stem cells. That a transplant can reconstitute the entire blood system underscores how central marrow is to blood production.

In myelofibrosis, scar tissue gradually replaces healthy marrow, physically squeezing out the blood-producing tissue. When the marrow can no longer keep up, the body activates a backup plan.

Backup Blood Production Outside the Bones

During fetal development, blood is not made in bones at all. The earliest blood cells form in the yolk sac, then production shifts to the liver and spleen before finally settling in the bone marrow around birth.¹⁸ Under normal circumstances, the marrow takes over permanently. But when marrow function is severely compromised in adults, the liver and spleen can revert to their fetal role and begin producing blood cells again. This is called extramedullary hematopoiesis, and while it helps compensate for marrow failure, it is far less efficient than normal marrow production and can cause the spleen and liver to enlarge dramatically.

Exercise and Blood Cell Production

Physical activity does more than consume oxygen; it can actually expand the body’s capacity to carry it. Regular exercise training has been shown to increase total hemoglobin and red blood cell mass. The mechanisms behind this appear to involve direct stimulation of blood cell production in the marrow, including expansion of the active blood-producing tissue and improvements to the marrow’s support environment.¹⁹ Hormonal changes triggered by exercise, including increases in EPO and other growth factors, also play a role. This is part of why endurance athletes develop higher red blood cell counts over time, and why moderate exercise is sometimes recommended as a complementary approach for people with mild anemia.

Blood Production Follows a Daily Clock

The release of certain immune cells from the bone marrow is not constant throughout the day. Research has found that the migration of immune cell precursors out of the marrow and into the bloodstream is governed by the body’s circadian rhythm. During the resting phase, a signaling molecule activates a receptor on precursor cells, triggering their release from the marrow into the blood. These cells then travel to tissues like the gut lining, where they take up residence as part of the local immune defense.²⁰

The logic behind this timing appears to be efficiency. Building new immune cells takes time and energy, so rather than trickling them out continuously, the body stockpiles them during waking hours and releases them in a coordinated wave during sleep. This daily cycle repeats indefinitely and is necessary to keep immune cell populations in barrier tissues at adequate levels. It is one reason why chronic sleep disruption does more than make you tired: it may interfere with this finely tuned release schedule and compromise immune readiness in the gut and other tissues exposed to the outside world.

An Evolutionary Latecomer

Given how central bone marrow is to blood production in humans, you might assume this arrangement is ancient. It is not, at least not in the way you would expect. Fossil evidence suggests that blood cell production inside long bones did not exist in the earliest land vertebrates. A study examining the limb bones of early four-legged animals found that the first species with an open marrow cavity suitable for blood production appeared roughly 60 million years after vertebrates had first moved onto land.²¹ This challenges a long-standing idea that blood production migrated into bones as a way to protect blood cells from the harsher conditions of terrestrial life. Instead, it appears that using bones as blood factories evolved well after the transition to land, for reasons that are still debated.

Fish and amphibians produce blood cells in the kidney and spleen rather than in bone marrow, a reminder that the bone-based system mammals rely on is just one evolutionary solution to the problem of making blood. The mammalian approach, with its specialized niches, its quality-control barriers at sinusoid walls, and its hormonal feedback loops, represents a highly refined version of blood production, but not the only one biology has come up with.